about
C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitusAutologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitusComparing the Ability of Anthropometric Indicators in Identifying Metabolic Syndrome in HIV PatientsDeterminants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in BrazilHealth-related quality of life in patients with type 1 diabetes mellitus in the different geographical regions of Brazil: data from the Brazilian Type 1 Diabetes Study GroupMetabolism genes are among the differentially expressed ones observed in lymphomononuclear cells of recently diagnosed type 1 diabetes mellitus patients.Gene expression profiles stratified according to type 1 diabetes mellitus susceptibility regions.Comparison of venous plasma glycemia and capillary glycemia for the screening of type 2 diabetes mellitus in the Japanese-Brazilian community of Mombuca (Guatapará-SP).Integrative analysis of the transcriptome profiles observed in type 1, type 2 and gestational diabetes mellitus reveals the role of inflammationPrevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola.Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group.Prevalence of the metabolic syndrome using two proposed definitions in a Japanese-Brazilians communityCan fasting plasma glucose and glycated hemoglobin levels predict oral complications following invasive dental procedures in patients with type 2 diabetes mellitus? A preliminary case-control study.Autologous hematopoietic stem cell transplantation for type 1 diabetes.Evaluation of Dietary Intake, Leisure-Time Physical Activity, and Metabolic Profile in Women with Mutation in the LMNA Gene.URINARY LOSS OF MICRONUTRIENTS IN DIABETIC PATIENTS ATTENDING A TERTIARY HOSPITAL SERVICE.Development of predictive equations for total and segmental body fat in HIV-seropositive patients.Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia.[Obesity and its relationship with cardiovascular risk factors in a Japanese-Brazilian population].Evaluation of cytokine production from peripheral blood mononuclear cells of type 1 diabetic patients.Association of HLA-G 3' untranslated region variants with type 1 diabetes mellitus.Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients.One-week intervention period led to improvements in glycemic control and reduction in DNA damage levels in patients with type 2 diabetes mellitus.Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients.A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight adiponectin and is associated with early-onset obesity and metabolic syndrome.Contribution of family social support to the metabolic control of people with diabetes mellitus: A randomized controlled clinical trial.Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.Supplementation of α-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes.Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals.Evaluation of plasma homocysteine level according to the C677T and A1298C polymorphism of the enzyme MTHRF in type 2 diabetic adults.In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control.Is HLA class II profile relevant for the study of large-scale differentially expressed genes in type 1 diabetes mellitus patients?Assessment of DNA damage and mRNA/miRNA transcriptional expression profiles in hyperglycemic versus non-hyperglycemic patients with type 2 diabetes mellitus.MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitusGene expression profiles displayed by peripheral blood mononuclear cells from patients with type 2 diabetes mellitus focusing on biological processes implicated on the pathogenesis of the diseaseEthics of Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus—ReplyEffect of BCG stimulus on proinflammatory cytokine production in laryngeal cancerEffect of Surgical Treatment on Lymphoproliferation in Advanced Supraglottic Laryngeal Cancer[Autonomic neuropathy: a high risk complication for type 1 diabetes mellitus]
P50
Q28241260-7BEBFB86-E65F-4DE9-839F-FF653E3110EBQ28297489-01A77226-7616-4A74-A684-A85628BD0CECQ28550389-2CC9DA5D-F322-41B6-B659-20966A74BBA6Q30830573-15A60910-BC7B-46FA-8309-B0597ADED36EQ31003296-14B184CF-21C9-493F-B03E-8EAA0C5C86E3Q33264777-E300B25A-E852-4B85-80CE-397D86BFD895Q33397070-4E60AFDB-B372-48B4-93E7-65110A164BFCQ33687494-EF4DF7BF-9B8A-4639-ACF1-BE2B03B3559FQ33789205-0AD27DA8-51CA-406D-88D4-217A4791C787Q34331640-40234FFC-B852-4D9A-B0A5-47847565784FQ34461828-A2D15E89-77D0-4559-B3BE-C3808F5DEC79Q36513518-2B0C0EEF-F818-4574-A061-4BE16BB28909Q36568261-FD55DD22-4EE3-495F-8B16-B3B63A726C17Q36727205-CFA2E52E-6C62-46DE-BFB4-DB8B43301E93Q37361377-81BD05BD-ECE3-464C-9D9A-61FF6976BD12Q38690798-5B71F5C8-BF27-435B-AA04-2989DDABC207Q41488569-4AE9B338-7A9A-4F06-926E-A759BBC56BA9Q41735892-3EBC0C7D-7C0F-4885-89C2-49A6510D6E81Q43045641-500CF03A-10C7-4B64-8799-0209BA39D617Q44374506-7F0E865A-968B-4AAD-AD39-1D73365CBEB9Q44840413-F4FB039F-655A-4FFC-9ADB-76919FF19187Q45883243-7CFB97CA-575D-4EA1-A0A2-8BB633453AD8Q46320499-72ACE19A-6143-4D83-B675-0C03C4975053Q46864102-775B11FC-A356-43C2-A2D8-F76DC5438755Q46904061-8F748FD3-2CE0-4DFF-B6B5-53AD6D33663CQ47188353-6A70C3A4-9D54-4B04-9402-320949D42831Q47777155-4FC7011C-B5F9-4EA0-8A04-4693CD535B11Q47954530-6B70BAC0-AC69-478C-9CF9-28D6170E6213Q51303641-085FDDE1-7F70-401A-BB8D-300D568154C5Q51318101-5FB93E9B-2AB7-4F1F-84FE-DE7E632A4F2EQ51349723-87AC2F0B-0C10-426F-A251-C359785954ABQ51484615-ECDC18E2-99F4-41C8-BE72-8480B35E4F14Q51928021-DE99227C-FE28-406C-972D-8DD43FA8C8C8Q53347328-CA650561-F5D0-4EC0-A23A-1E1F8D7FF5EAQ58285874-7D559C7B-3090-4887-8B8A-BB3E850A52E3Q58286057-86178938-F6EE-46AA-9894-294F3023802EQ58855540-A4AD2D03-2B03-4425-81C8-0896EF5F090BQ59189934-CB34D67F-3A55-4863-BEF8-0A1274BB40C0Q59189937-EE09EBAE-804B-4578-B88C-F601ED91F253Q81157492-3DDBE3A4-3A8B-4F5C-AFAB-39F55CF1E8AA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria C Foss-Freitas
@ast
Maria C Foss-Freitas
@en
Maria C Foss-Freitas
@es
Maria C Foss-Freitas
@nl
Maria C Foss-Freitas
@sl
type
label
Maria C Foss-Freitas
@ast
Maria C Foss-Freitas
@en
Maria C Foss-Freitas
@es
Maria C Foss-Freitas
@nl
Maria C Foss-Freitas
@sl
prefLabel
Maria C Foss-Freitas
@ast
Maria C Foss-Freitas
@en
Maria C Foss-Freitas
@es
Maria C Foss-Freitas
@nl
Maria C Foss-Freitas
@sl
P1053
F-1197-2013
P106
P1153
6507274211
P21
P31
P3829
P496
0000-0002-1350-1125